Aidea Pharma(SH:688488) Xin Lang Cai Jing·2026-01-16 06:36Group 1 - Eddie Pharmaceuticals' stock price increased by 5.15% on January 16, reaching 22.06 CNY per share, with a trading volume of 520 million CNY and a turnover rate of 6.05%, resulting in a total market capitalization of 9.282 billion CNY [1] - The stock has risen for three consecutive days, with a cumulative increase of 24.14% during this period [1] - The company, established on December 15, 2009, and listed on July 20, 2020, focuses on the exploration, research, and sales of innovative chemical drugs and human-derived protein products, with revenue composition as follows: human-derived proteins 41.11%, new drugs 35.69%, diagnostic equipment and reagents 13.62%, generic drugs 9.47%, and others 0.11% [1] Group 2 - Among the top ten circulating shareholders of Eddie Pharmaceuticals, the Xingsheng Global Fund has a fund that entered the top ten in the third quarter, holding 6.229 million shares, which accounts for 1.48% of the circulating shares [2] - The estimated floating profit for today is approximately 6.7273 million CNY, with a total floating profit of 25.4142 million CNY during the three-day increase [2] - The Xingsheng Global Fund's mixed fund (LOF) A (163415) was established on December 18, 2012, with a latest scale of 14.567 billion CNY, yielding 6.54% this year, ranking 2504 out of 8847 in its category, and 48.84% over the past year, ranking 2241 out of 8094 [2]